Developed by Abbott and approved by the US FDA, this cutting-edge stent is designed to treat chronic ischemia below the knee, a condition that often leads to amputations. The stent keeps the blood vessel open while releasing a drug that promotes healing before dissolving, significantly reducing the risk of long-term complications.
Dr. Arif Al Nouryani, Director of Al Qassimi Hospital, hailed the success as a major milestone for UAE healthcare. He emphasised that this achievement improves patient outcomes by addressing hardened arteries below the knee, a life-threatening condition. The new stent offers an innovative solution that enhances quality of life and reduces mortality rates.
Sameh Al Mawass, Vice President of Vascular Surgery at Abbott EMEA; Dr. Zaki Al Mazki, Head of Vascular Surgery; and Dr. Khalid Al Naqbi, Head of Interventional Radiology expressed pride in the UAE’s achievement, particularly at Al Qassimi Hospital, in being the first in the region to implant the advanced stent.
They went on to say that the accomplishment aligns with the Emirates Health Services Corporation’s commitment to advancing healthcare and incorporating the latest medical technologies. It reflects the broader goals of the “We the Emirates” Vision 2031 and the UAE Centennial 2071, which prioritise innovation and improved living standards in vital sectors, including healthcare.
.
.
For an optimal experience, please
